<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:bovine-ojs-tamu.tdl.org:article/3822</identifier>
				<datestamp>2020-02-06T08:43:54Z</datestamp>
				<setSpec>aabp:RS2</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Relationship between uterine pathology and depletion of oxytetracycline concentrations in plasma and milk after intrauterine infusion</dc:title>
	<dc:creator xml:lang="en">Gorden, P. J.</dc:creator>
	<dc:creator xml:lang="en">Coetzee, J. F.</dc:creator>
	<dc:creator xml:lang="en">Lee, C. J.</dc:creator>
	<dc:creator xml:lang="en">Wulf, L. W.</dc:creator>
	<dc:subject xml:lang="en">uterus</dc:subject>
	<dc:subject xml:lang="en">intrauterine treatment</dc:subject>
	<dc:subject xml:lang="en">antimicrobial</dc:subject>
	<dc:subject xml:lang="en">dairy cattle</dc:subject>
	<dc:subject xml:lang="en">residue</dc:subject>
	<dc:subject xml:lang="en">oxytetracycline</dc:subject>
	<dc:subject xml:lang="en">uterine pathology</dc:subject>
	<dc:description xml:lang="en">Up to 90% of dairy cows develop bacterial contamination of the uterus during the first week after calving. Intrauterine treatment with antimicrobials is commonly practiced on dairy farms, even though studies demonstrating improved reproductive performance after treatment are lacking. Intrauterine infusion of antimicrobials can result in costly milk discard, and increases the risk for antimicrobial residue in bulk-tank milk intended for human consumption. Because there are currently no antimicrobials approved for intrauterine administration in cattle, the veterinarian is primarily responsible for ensuring that milk from treated cows is free from antimicrobial residues. Results of previous trials have indicated considerable variation in the depletion profile of drugs after intrauterine infusion. For this study, we hypothesized that the variability in the elimination of oxytetracycline in milk is associated with the extent of uterine pathology among cases.</dc:description>
	<dc:publisher xml:lang="en">American Association of Bovine Practitioners</dc:publisher>
	<dc:date>2013-09-19</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://bovine-ojs-tamu.tdl.org/aabp/article/view/3822</dc:identifier>
	<dc:identifier>10.21423/aabppro20133822</dc:identifier>
	<dc:source xml:lang="en">American Association of Bovine Practitioners  Conference Proceedings; 2013; 161</dc:source>
	<dc:source>1079-9737</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://bovine-ojs-tamu.tdl.org/aabp/article/view/3822/3761</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2013 American Association of Bovine Practitioners</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
